a n a ly s i s If trait-associated variants alter regulatory regions, then they should fall within chromatin marks in relevant cell types. However, it is unclear which of the many marks are most useful in defining cell types associated with disease and fine mapping variants. We hypothesized that informative marks are phenotypically cell type specific; that is, SNPs associated with the same trait likely overlap marks in the same cell type. We examined 15 chromatin marks and found that those highlighting active gene regulation were phenotypically cell type specific. Trimethylation of histone H3 at lysine 4 (H3K4me3) was the most phenotypically cell type specific (P < 1 × 10 −6 ), driven by colocalization of variants and marks rather than gene proximity (P < 0.001). H3K4me3 peaks overlapped with 37 SNPs for plasma low-density lipoprotein concentration in the liver (P < 7 × 10 −5 ), 31 SNPs for rheumatoid arthritis within CD4 + regulatory T cells (P = 1 × 10 −4 ), 67 SNPs for type 2 diabetes in pancreatic islet cells (P = 0.003) and the liver (P = 0.003), and 14 SNPs for neuropsychiatric disease in neuronal tissues (P = 0.007). We show how cell type-specific H3K4me3 peaks can inform the fine mapping of associated SNPs to identify causal variation.
a n a ly s i s If trait-associated variants alter regulatory regions, then they should fall within chromatin marks in relevant cell types. However, it is unclear which of the many marks are most useful in defining cell types associated with disease and fine mapping variants. We hypothesized that informative marks are phenotypically cell type specific; that is, SNPs associated with the same trait likely overlap marks in the same cell type. We examined 15 chromatin marks and found that those highlighting active gene regulation were phenotypically cell type specific. Trimethylation of histone H3 at lysine 4 (H3K4me3) was the most phenotypically cell type specific (P < 1 × 10 −6 ), driven by colocalization of variants and marks rather than gene proximity (P < 0.001). H3K4me3 peaks overlapped with 37 SNPs for plasma low-density lipoprotein concentration in the liver (P < 7 × 10 −5 ), 31 SNPs for rheumatoid arthritis within CD4 + regulatory T cells (P = 1 × 10 −4 ), 67 SNPs for type 2 diabetes in pancreatic islet cells (P = 0.003) and the liver (P = 0.003), and 14 SNPs for neuropsychiatric disease in neuronal tissues (P = 0.007). We show how cell type-specific H3K4me3 peaks can inform the fine mapping of associated SNPs to identify causal variation.
Recent work showing that common phenotypically associated SNPs are enriched for expression quantitative trait loci (eQTLs) [1] [2] [3] [4] [5] [6] suggests that they might act by altering gene regulatory regions. One example is a common non-coding variant associated with plasma low-density lipoprotein (LDL) concentration. This variant modifies a CEBPB transcription factor-binding site in an enhancer and, in doing so, alters the expression of SORT1, a gene that affects plasma LDL concentration 7 . Another similar example is an intergenic risk allele for systemic lupus erythematosus (SLE) that decreases TNFAIP3 transcription by modifying the nuclear factor (NF)-κb-binding site within a promoter 8 . Whereas many eQTLs and regulatory variants act universally, the ones most relevant to disease might have tissue specific activity 6 . The cell type specificity of regulatory elements is one of the major limitations in pursuing functional studies to investigate the regulatory potential of common alleles [9] [10] [11] [12] [13] .
One approach to identify regulatory elements influenced by common variants involves assaying epigenetic chromatin marks [14] [15] [16] . For example, H3K4me3 and monomethylation at H3K4 (H3K4me1) highlight active promoters and enhancers. But, a practical challenge of this approach is that dozens of chromatin marks might potentially be assayed 17 , and it is prohibitive to conduct studies on all of them in large numbers of different tissues or in samples collected from many individuals. However, because chromatin marks colocalize 18 , the status of a small subset of the most informative marks might be characterized, allowing for more focused assays in tissue libraries and populations to link variants to regulatory mechanisms. Additionally, it is challenging for a given phenotype to know which cell type(s) are most useful to assay chromatin marks in order to fine map risk alleles. If the critical cell types were known, then it might be possible to identify the biologically important cell type-specific eQTLs.
Here, we hypothesize that a proportion of alleles for a given phenotype influence gene regulation by altering regulatory elements that control expression within the cell types most relevant to the phenotype. If this is the case, then variants associated with the same phenotype should overlap marks preferentially occurring within the same cell type. Therefore, to identify the most informative chromatin marks, we quantify the degree to which their activity in specific cell types near phenotypically associated variants tracks with phenotype. We then show how those chromatin marks that are most phenotypically cell type specific can identify causal cell types, asserting that cell type-specific marks might be used to fine map and identify the plausible causal variant at a particular locus.
RESULTS

Summary of statistical methods
We first sought to define a score that corresponds to the possibility that a phenotypically associated SNP or a variant in tight linkage disequilibrium (LD) with it can alter cell type-specific gene regulation, as highlighted by a specific chromatin mark. We define chromatin marks as precise positions in the genome where there is a significant Chromatin marks identify critical cell types for fine mapping complex trait variants excess of reads from chromatin immunoprecipitation and sequencing (ChIP-seq) data over control sequencing data. We assume that variants close to or directly under tall chromatin mark peaks in specific cell types might be involved in cell type-specific gene regulation; on the other hand, variants that are far from chromatin mark peaks are much less likely to have a direct role in gene regulation. First, for each phenotypically associated SNP, we identified each SNP or insertion and/or deletion (indel) in tight LD (r 2 > 0.8 in 1000 Genomes Project data 19 ; Fig. 1a) . Next, for each cell type, we assigned each variant in LD a score proportional to the height of the nearest chromatin mark peak (referred to as h; Online Methods) divided by the physical distance to the summit (h/d in Fig. 1b ; referred to as s; Online Methods). If the physical distance to the nearest peak is more than 2.5 kb, then the score is set to 0 to obviate any confounding distal effects. Thus, a variant in LD directly under a strong peak will receive a very high score. For each cell type, we assigned the phenotypically associated SNP the maximum score achieved by any of its variants in LD. To quantify the specificity of signals across cell types (as opposed to the absolute magnitude), we normalized the h/d scores so that the Euclidean metric across cell types was one (normalized h/d scores (sn; Online Methods). Thus, a SNP within a chromatin mark that is active in only one cell type will have a high score of 1 in that cell type and 0 in others. In contrast, a SNP close to chromatin marks that are not cell type specific will have similarly modest scores across cell types.
Then, we wanted to quantify the phenotypic cell type specificity of the overlap between SNPs and chromatin marks. To do this, we identified sets of SNPs associated with different phenotypes and then assessed the phenotypic cell type specificity of different marks (Fig. 1c) . For informative marks, one or few cell types should consistently score highly across many of the SNPs for a given phenotype. For an uninformative chromatin mark, the cell types with the greatest scores vary from SNP to SNP within the same phenotype.
Therefore, for informative marks, there should be minimal deviation of scores within a phenotype across multiple cell types. To quantify the phenotypic cell type specificity of a chromatin mark, we defined a metric representing the variation of signal seen within a cell type within a specific phenotype (referred to as d; Online Methods). We evaluated the statistical significance of this metric with permutations with which we randomly reassigned SNPs to phenotypes (Fig. 1d) . This permutation strategy restricts analysis to only phenotypically associated SNPs and, in doing so, avoids biases that might result from known differences between phenotypically associated SNPs and non-phenotypically associated SNPs in local LD structure, gene density and epigenetic activity. We note that this approach accurately estimates type I error (Supplementary Fig. 1a ).
Active gene regulation is phenotypically cell type specific
To test the phenotypic cell type specificity of individual marks, we identified a set of SNPs associated with any one of many complex traits 20 . We selected only SNPs associated in European populations to facilitate LD calculations. To ensure adequate power, we selected only those traits that had at least 15 reported associations in European populations. Then, we pruned SNPs by LD so that they were all independent (r 2 < 0.1 and >100 kb away from other associated SNPs in the genome; Online Methods). This resulted in a set of 510 independent SNPs associated with 31 complex traits. After defining the genomic locations and heights of peaks for 15 chromatin marks assayed in 14 Encyclopedia of DNA Elements (ENCODE) cell types 15 ( Supplementary Table 1) , we observed statistically significant phenotypic cell type specificity for 4 marks (P < 0.0033 = 0.05/15; Fig. 2) . The most strongly associated chromatin marks were H3K4me3 and acetylation of histone H3 at lysine 9 (H3K9ac) (P < 1 × 10 −6 ), which are known to highlight active gene promoters 16, 21 . In fact, all four most significant modifications are known to occur at regions of the Figure 1 Overview of the statistical approach. (a) For phenotypically associated variants, other variants in tight LD are found. For each SNP associated with a phenotype from genetic studies (lead SNP, blue diamond; top), we define a locus by identifying SNPs in tight LD (r 2 > 0.8, dashed red line; bottom) using data from the 1000 Genomes Project (blue dots; bottom). (b) Each locus is scored on the height and distance of the nearest peak to a variant in LD. For a selected chromatin mark, we define peaks (red) in n cell types across the genome. For each SNP in the locus (blue diamond and light-blue circles), we compute a score equal to the height of the closest peak (vertical purple line) divided by the distance to the summit in each of the n cell types (horizontal purple line). In each locus within each cell type, we note the value of the SNP with the highest score: this measure reflects the overlap between a locus and a cell type-specific regulatory element. (c) Across many phenotypes, we assess whether marks overlap alleles in specific cell types. Here, the measure of cell type specificity of each risk locus is represented by the intensity of red color. A phenotypically cell type-specific mark should consistently give signal in one or a small number of cell types for a given phenotype (yellow outline). We quantify the phenotypic cell type specificity of each mark. (d) Permutations are performed to assess the significance of phenotypic cell type specificity. To compute the significance of the phenotypic cell type specificity for a chromatin mark, we permutate SNPs from different loci across phenotypes; this preserves tissue-specific signals without altering the correlation and prevalence of tissue-specific signals. Cell types a n a ly s i s npg a n a ly s i s genome involved in active gene transcription; DNase I hypersensitivity sites (DHSs; P < 1 × 10 −3 ) and dimethylation of histone H3 at lysine 79 (H3K79me2; P < 1 × 10 −5 ) identify active promoter, enhancer or transcribed regions. Because some chromatin marks colocalize ( Supplementary Fig. 2 ), we performed conditional analyses to assess whether chromatin marks contributed to phenotypic cell type specificity independently ( Supplementary Fig. 3 ). We observed that the highly significant associations of H3K4me3, DHSs and H3K9ac were generally not independent. In contrast, we found that chromatin marks that did not correspond to active gene regulation were not phenotypically cell type specific. In particular, H3K9me1, H3K9me3, CTCF-binding sites and trimethylation at histone H3 lysine 27 (H3K27me3), highlighting transcriptionally repressed heterochromatic insulator and polycomb-repressed regions, respectively, showed no evidence of being phenotypically cell type specific (P > 0.40).
To assess the reproducibility of these results, we conducted a similar analysis of data from the US National Institutes of Health (NIH) Epigenomics Project, consisting of assays for 6 different chromatin marks in 38 different cell types 22 (Supplementary Table 2 ). We again observed that the most informative mark was H3K4me3 (P < 1 × 10 −6 ), along with H3K4me1 (Fig. 2) . H3K9ac was more nominally significant (P = 0.03), perhaps owing to the fewer cell types assayed in this experiment. The concordance of the results from these two data sets was reassuring when considering that the data from the ENCODE Project were obtained on cell lines, whereas most of the NIH Epigenomics Project data were obtained using primary cell types.
Our approach benefits from taking advantage of 1000 Genomes Project data to identify variants in LD (Fig. 1a) . Repeating our analysis using only the reported lead SNPs and not examining SNPs in LD resulted in considerably less significant results ( Supplementary  Fig. 1b) . We note that some of the variation in phenotypic cell type specificity could be related to the variable number of assayed cell types for different chromatin marks; power to detect phenotypic cell type specificity correlates with the number of assayed cell types ( Supplementary Fig. 4 ).
Variants colocalize with cell type-specific H3K4me3 peaks
Because chromatin marks tend to concentrate in and around genes, we considered the possibility that the observed overlap between H3K4me3 peaks and variants might be an artifact of proximity to gene transcript sequences with phenotypically cell type specific expression. To assess the role of the specific peak locations versus proximity to specifically expressed genes, we repeated our analyses after randomly shifting the specific location of peaks locally (± 10 kb, s.d. of 2.5 kb) within phenotypically associated loci. While these small shifts would maintain the proximity of peaks to genes, they would disrupt the specific colocalization of variants and H3K4me3 peaks. Indeed, in 1,000 such experiments, we found that shifting peak locations lowered the significance of phenotypic cell type specificity (median P = 0.03), and we did not observe any instance where the phenotypic cell type specificity was more significant than it was in the actual data ( Supplementary Fig. 5 ). This result strongly suggests that the specific colocalization of variants in LD with phenotypically associated SNPs and H3K4me3 peaks rather than proximity to gene structures is driving the phenotypic cell type specificity signal (P < 0.001 by permutation).
Enhancers and promoters underlie phenotypic cell type specificity
To understand whether the phenotypic cell type specificity that we observed was driven by the activity of promoters or enhancers, we divided chromatin peaks into those falling within proximal promoter regions (including the transcriptional start site (TSS) ± 2 kb) and those falling outside of promoter regions and repeated our analysis. Whereas phenotypic cell type specificity was seen both within and outside of the immediate promoter regions, H3K4me3, H3K79me2 and DHSs were more significantly phenotypically cell type specific outside of promoter regions than within (Supplementary Fig. 6 ). We note that, although H3K4me3 marks are not generally thought of as being enriched in enhancers, there was evidence that they can be enriched in strong and disease-associated enhancers 9, 23, 24 . Alternatively, H3K4me3 enrichment outside of promoter sites might also represent unannotated sites.
We further assessed the phenotypic cell type specificity of previously published functional annotations on the basis of hidden Markov model states capturing information on nine separate chromatin marks 9 . We observed that hidden states 4 and 5, corresponding to active proximal enhancers and active distal enhancers, respectively, were most significantly phenotypically cell type specific ( Supplementary  Fig. 7 ). State 4 is highly enriched for H3K4me3 peaks, the mark that we observed to be the most phenotypically cell type specific.
Identification of key cell types for four phenotypes
We identified the cell types within which common variants likely influence gene regulation using published SNPs for 4 distinct phenotypes ( Fig. 3 and Supplementary Table 3 ) and H3K4me3 data from the Epigenomics Project for a panel of 34 cell-types 22 . We selected these phenotypes because there is a reasonable sense of what the critical cell types might be and because a sufficient number of associated SNPs had been identified. For each phenotype, we assigned a cell type specificity score to each of its associated variants (Fig. 1a,b Figure 2 Evaluating the significance of phenotypic cell type specificity for different marks. We used two data sets of marks assayed in different cell types: the ENCODE Project and NIH Epigenomics Project. For each mark, we performed up to 1 million permutations of SNPs and phenotypes to calculate the null distribution of phenotypic cell type specificity for comparison to observed phenotypic cell type specificity. Below, we show the observed phenotypic cell type specificity (green lines) against the null distribution (black and gray density plots). Above, we plot the corresponding P values. The red dashed line indicates the significance threshold after correcting for the testing of multiple independent hypotheses. a n a ly s i s
Online Methods) and compared to scores from equal-sized sets of matched SNP sets sampled from 45,950 LD-pruned SNPs 3 .
can be controversial [28] [29] [30] . When we tested the 31 SNPs associated with rheumatoid arthritis 31 , we observed that they implicated 1,328 H3K4me3 peaks in 34 tissues, with the most significant association to CD4 + T cells and, in particular, CD4 + regulatory T (T reg ) cells (P = 1.3 × 10 −4 ; Fig. 3b ). The phenotypically similar CD4 + memory T cells were also highly significantly associated (P = 7.0 × 10 −4 ) 32 .
Of the 31 SNPs associated with rheumatoid arthritis, we found that 6 (19.3%) were close to chromatin marks that were highly specific to CD4 + T reg cells, with relative specificity of 0.53 or greater (permuted 95th-percentile threshold; Fig. 4b ). These 6 SNPs are generally in tight LD with a variant that is very close to cell type-specific H3K4me3 peaks (median of 37 bp away; see Supplementary Table 3 for details on the specific SNPs). In instances where dense genotyping has been applied to localize the association signal, we speculate that cell type-specific overlap might become more apparent. Indeed, for the 31 loci associated with rheumatoid arthritis, we examined recent results from a fine-mapping study using the dense genotyping platform the Immunochip 33 . Indeed, when repeating the analysis with the newly defined index SNPs from each locus using dense genotyping data, we found that the significance of the enrichment for CD4 + T reg cells increased (5.1 × 10 −5 ; Supplementary Fig. 10 ) and that the median specificity score for each locus increased from 0.13 to 0.16.
Application to psychiatric disorders implicates neuronal tissues
The 14 independent SNPs from neuropsychiatric disorders 34, 35 mapped within 874 H3K4me3 peaks. Despite the limited power of this analysis, we were encouraged to see that these SNP associations implicated multiple neuronal tissues, including the anterior caudate nucleus (P = 0.0076) and the mid-frontal lobe of the brain (P = 0.044) (Fig. 3c) ; we also observed a likely spurious association with colonic smooth muscle (P = 0.026). The role of the frontal lobe in neuropsychiatric disease in particular has long been appreciated [36] [37] [38] . Although none Because phenotypically associated SNPs have more epigenetic activity than other SNPs, we were careful to match sampled SNPs so that they had similar total numbers of H3K4me3 peaks across all 34 cell types as associated SNPs. Results were generally consistent in a more stringent analysis when we sampled instead from only phenotypically associated SNPs from the National Human Genome Research Institute (NHGRI) genome-wide association study (GWAS) catalog 20 ( Supplementary Fig. 8 ). In addition to these phenotypes, we present separately the results for four additional phenotypes, B-cell-specific cis eQTL associations, SLE, type 1 diabetes (T1D) and body mass index (BMI) ( Supplementary Fig. 9 ); in all of those instances, except BMI, we were able to identify highly significant cell types.
Application to plasma LDL concentration implicates liver
As a positive control, we tested 37 SNPs associated with LDL concentration 25 for overlap with H3K4me3 marks in different tissues. These variants should implicate regulatory activity within the liver, according to previous work 7, 26, 27 . In aggregate, we observed that the 37 SNPs implicated a total of 1,501 H3K4me3 peaks in 34 different cell types. The most significant cell type was adult liver tissue (P = 7.2 × 10 −5 ; Fig. 3a) . We observed overlap with liver-specific peaks using other phenotypically cell type-specific marks, including H3K9ac (P = 0.003) and H3K4me1 (P = 0.002). In contrast, we observed little association with liver for the H3K27me3 or H3K9me3 marks ( Fig. 2 and Supplementary Table 4) . Examining the relative proximity and specificity of the SNPs within 10,000 sets of matched SNP sets used to calculate statistical significance, we identified the 95th-percentile threshold at a score of 0.58 (Fig. 4a) . Of the 37 SNPs associated with LDL concentration, 7 (19%) were near to a highly liver-specific chromatin mark at this threshold. These seven SNPs are generally in tight LD with a variant that is very close to cell typespecific H3K4me3 peaks (median of 132 bp away; see Supplementary  Table 3 for details on the specific SNPs).
Application to rheumatoid arthritis implicates CD4 + T reg cells
For rheumatoid arthritis and other autoimmune diseases, the critical immune cell types are often not clearly defined in the literature and npg a n a ly s i s of these results reached a conservative level of significance after correcting for multiple-hypothesis testing, we are hopeful that additional SNP discoveries will help clarify this result further. Of the 14 SNPs associated with neuropsychiatric disorders, 3 (21%) had a tissuespecific chromatin mark within the anterior caudate, with a relative specificity of 0.28 or greater (permuted 95th percentile; Fig. 4c ).
Application to T2D implicates pancreatic islets and liver
In certain instances, it might be plausible that multiple tissues could be implicated in a disease. When we examined 67 SNPs for type 2 diabetes (T2D) [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] , implicating a total of 2,776 H3K4me3 peaks within 34 different cell types, we observed the most significant enrichment in pancreatic islets (P = 0.0061) and the liver (P = 0.0079) (Fig. 3d) . In particular, of the 67 SNPs associated with type 2 diabetes, 14 (20.1%) were either highly specific for chromatin marks within the liver (at a 0.57 permuted 95th-percentile threshold) or pancreatic islets (at a 0.65 permuted 95th-percentile threshold); these SNPs are in tight LD with a marker that has a median distance of 46 bp from the summit of a cell type-specific peak. When we tested the pancreatic islet and liver tissues together, we found that the combination of liver and pancreatic islets was even more significant than the tissues individually (P = 2.0 × 10 −4 ; Online Methods) and was more significant than all other possible tissue pairs. We found that the SNPs driving the overlap in the two tissues were distinct (Fig. 4d) . When we removed the SNPs most specific for pancreatic islet marks (score > 0.3), we observed that enrichment in liver was even more apparent (P = 0.0032); similarly, when we removed the SNPs most specific for overlap with liver marks (score > 0.3), we observed that the enrichment in pancreatic islets was also more apparent (P = 0.0026). Both islet cells and the liver have long been known to have a key role in mediating glucose synthesis, insulin secretion and diabetes 51 .
Fine mapping with cell type-specific H3K4me3 peaks
One of the major challenges in understanding complex trait associations is to identify the causal variants and the mechanisms through which they affect genes. Associated variants can be fine mapped to variants in tight LD within cell type-specific chromatin marks in the appropriate cell type. Here, we present examples where cell typespecific H3K4me3 peaks can potentially be used to localize associated variants to causal variants. First, we considered the rs629301 SNP that is associated with plasma LDL concentration in the region including the SORT1 gene (Fig. 5a) . A liver-specific H3K4me3 peak, not seen as prominently in other cell types, overlapped with this SNP and three other variants in tight LD with it. This H3K4me3 peak is located far from the TSS region and corresponds to a hepatocyte enhancer region 7 . The closest SNP to the summit of the peak (87 bp away) is the rs12740374 functional variant. This variant is known to alter a CEBPB-binding site within the enhancer region controlling SORT1.
Another example is provided by the locus for T2D represented by the rs704184 reported SNP association. rs10814915, tightly in LD with the reported GWAS SNP (r 2 = 0.93), scored highly for pancreatic islets but showed no tissue specificity for the liver (Fig. 5b) . This SNP located only 84 bp away from the summit of a highly pancreatic islet-specific peak. rs10814915 is predicted to be present within a sequence bound by the glucocorticoid receptor (GR) 52 , which is known to have a role in pancreatic islets and glucose regulation. The SNP resides within an intron of the GLIS3 gene, which is involved in the development of pancreatic islets.
Finally, we examined the locus for rheumatoid arthritis defined by a reported association with the rs13119723 SNP in the intron of a gene with unknown function, KIAA1109. This SNP is in LD with other variants spanning over 500 kb within this locus, rendering fine-mapping efforts particularly challenging. We identified a SNP, rs13140464, in tight LD with rs13119723 (r 2 = 0.9) (Fig. 5c) , which maps only 116 bp from the summit of the H3K4me3 peak, which is highly specific to CD4 + T reg cells with a score of 0.63. This SNP is located between the IL2 and IL21 genes, 122 kb downstream of IL2 and 34 kb upstream of IL21, and is 280 kb away from the published SNP. It is tempting to speculate that rs13140464 might act by altering a highly cell type-specific regulatory sequence controlling IL2 expression, which has a key role in CD4 + T reg maturation 53 . We compare these scores to specificity scores in the same tissue of 10,000 sampled sets of matched SNPs from HapMap (yellow density plots). We plot the median specificity for both the distribution of observed SNPs and the sampled sets of matched SNPs (solid lines). Also, we present the 95th-percentile threshold for the sampled sets of matched SNPs (dashed line), which we use as a specificity cutoff. For each phenotype, about one-fourth of variants overlap cell type-specific H3K4me3 peaks. npg a n a ly s i s
DISCUSSION
In this study, we demonstrated that chromatin marks highlighting active regulatory regions, such as H3K4me3, H3K9ac and DHSs, overlap phenotypically associated variants; furthermore, this overlap is phenotypically cell type specific. These results strongly support the hypothesis that many complex disease and trait alleles might act by influencing gene regulation in a cell type-specific manner. In addition, we quantified the degree to which different marks are cell type specific in their overlap with phenotypically associated SNPs. These cell type-specific marks might not only be used to connect phenotypes to specific cell types, but they might also be useful in mapping phenotype-associated SNPs to potential regulatory variants. In particular, we consistently observed that H3K4me3 marks could be used to effectively identify specific cell types that are enriched among specific phenotypes. We note that this statistical approach can be applied to assess the significance of other chromatin marks or other cell type-specific gene annotations as they become available.
In the phenotypes that we examined, we found that about onefourth of associated variants could be connected to a highly cell typespecific mark within a critical cell type (Fig. 5) . In instances where we do not observe a SNP in tight LD within a highly cell type-specific H3K4me3 peak, it is possible that a regulatory region that is not cell type specific might be altered. Alternatively, in some instances the reported SNP association will need to be further refined with dense genotyping, or undiscovered variants in tight LD will need to be ascertained through sequencing, before the effect of a cell type-specific peak can be identified. Finally, for many phenotypes, multiple cell types could be involved, in which case this approach might have limited efficacy. We demonstrated one example of this type of scenario in T2D, where we detected effects both in liver and pancreatic islet cell types.
We acknowledge that our approach is potentially sensitive to the diversity and number of cell types assayed. For instance, a limited application to a set of hematopoietic cell types might not be particularly informative if a set of purely neurological phenotypes is assayed. We note that our approach depends critically on technical factors-for instance, the quality of antibody reagents, experimental protocols or other technical factors that might introduce noise into specific chromatin mark assays could mitigate true signals. Our approach may perform better on the chromatin marks with higher quality assays.
Once variants and cell types are identified, they will likely be excellent candidates for cell type-specific functional investigations, including allelic imbalance assays to define cis-eQTL activity 54 , cell type-specific DHS quantitative trait locus (dsQTL) analyses 55 and identification of active transcription factor-binding sites. These cell type-specific investigations in appropriately chosen cell types might ultimately help to lead investigators from common disease variation to causal variants and molecular mechanisms.
URLs. All software is available online at http://www.broadinstitute. org/mpg/epigwas/. ENCODE, http://genome.ucsc.edu/ENCODE/ downloads.html; NIH Roadmap Epigenomics Mapping Consortium, http://www.roadmapepigenomics.org/; NHGRI GWAS catalog, http:// www.genome.gov/gwastudies/.
METHODS
Methods and any associated references are available in the online version of the paper. Figure 5 Selected phenotypically associated loci with high cell type specificity. We present three examples of loci with cell type-specific overlap with H3K4me3 peaks. Top, genomic coordinates and genes near the associated SNP. Middle, lead SNP (blue diamond) and other nearby SNPs from the 1000 Genomes Project (red dots correspond to those with high r 2 , blue dots correspond to those with low r 2 ). We also show the SNP that is closest to the cell type-specific peak (red diamond). Bottom, H3K4me3 sequence tag counts for selected cell types. Colored horizontal lines in the tissue panels correspond to peak calls. Dashed vertical lines mark the summits of phenotypically cell type-specific peaks. (a-c) Shown are the SORT1 locus for LDL (a), the GLIS3 locus for T2D (b) and the IL2-IL21 locus for rheumatoid arthritis (c).
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